Not for publication in the U.S.
- The Atellica LumiQ Analyzer expands access to modern urinalysis testing by delivering reliable, laboratory-quality results in decentralized and point-of-care settings.
- The system supports earlier detection and monitoring of conditions such as kidney disease, urinary tract infections, pregnancy, and diabetes through standardized testing and rapid clinical insights.
- Built in connectivity, integrated quality safeguards, and scalable testing capabilities help simplify workflows, support quality assurance, and enable testing closer to the patient.
Siemens Healthineers is expanding access to modern urinalysis testing in Canada with the Atellica LumIQ Analyzer, a portable and scalable point-of-care instrument designed for use on the frontlines of patient care. The system helps clinicians detect and monitor conditions such as kidney disease, urinary tract infections, pregnancy and diabetes, while enabling testing closer to the patient and providing earlier clinical insights than traditional laboratory-based methods.
Chronic kidney disease affects more than 10% of the global population and for millions of people, it progresses silently until treatments such as dialysis or kidney transplant become necessary - often when options are limited and costs are high. Early detection, intervention, and routine monitoring through urinalysis can help slow or stop disease progression. In many care settings, testing still relies on visually reading reagent strips, a method that introduces variability in both test execution and result interpretation.
As Canadian healthcare systems continue to focus on improving access to diagnostic testing closer to where patients live and receive care, solutions such as the Atellica LumIQ Analyzer can play an important role. By bringing reliable, laboratory-quality urinalysis out of the central laboratory and into primary care, community care, and other decentralized testing environments, the analyzer enables faster clinical decision-making, simplifies testing workflows, and helps reduce unnecessary referrals and hospital visits. At a time when healthcare organizations across Canada face ongoing resource and capacity pressures, technologies that standardize quality and deliver immediate results can support more integrated models of care while improving the experience for both clinicians and patients.
"For decades, the Clinitek Status+ analyzer has provided a trusted foundation for urine testing, delivering simple, reliable results where they are needed most." said Sarah Gamble, head of Point-Of-Care Diagnostics in Canada. Atellica LumIQ builds on that legacy with a modernized user experience, enhanced connectivity, and integrated quality safeguards that make testing even easier and more accessible across a broader range of care settings. As healthcare continues to shift closer to the patient, with growing support for point-of-care testing in EMS, pharmacies, and other community-based environments, Atellica LumIQ helps expand access to timely diagnostics while reducing the burden on clinics and hospitals.
Building on a decades-long legacy of leadership in urinalysis, Siemens Healthineers is advancing the category by pairing proven chemistry with intelligent, digital innovation. The analyzer’s modular design enables care sites to scale testing capacity as demand grows, helping accelerate turnaround times and support faster clinical decision-making. By combining urinalysis and hCG pregnancy testing on a single analyzer, users can streamline workflows at a low total cost of ownership.
Designed for decentralized testing environments outside of the laboratory, the system offers an intuitive user interface, compact footprint, and built-in Wi-Fi for seamless connectivity to hospital and laboratory information systems. When paired with Atellica Connect POC Insights or the POCcelerator Data Management System, point-of-care coordinators and administrators can oversee multiple analyzers, access actionable insights, and support quality assurance and troubleshooting.
For more information about the Atellica LumIQ Analyzer, visit :
Atellica LumIQ Analyzer- Siemens Healthineers Canada
Image of the Siemens Healthineers Atellica LumIQ Analyzer
Media Contact:
Mekha Puthooran
Marketing Communications Manager, Lab Solutions and Point of Care
Siemens Healthineers, Canada
mekha.puthooran@siemens-healthineers.com
About Siemens Healthineers:
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 73,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at www.siemens-healthineers.com.

